Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline Sampling to Promote Smoking Cessation
NCT03742154Phase 1Completed
- Sponsor
- Medical University of South Carolina
- Start
- Dec 2018
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of varenicline in nicotine dependence (2 arms), sponsored by Medical University of South Carolina. Primary endpoint: Quit Attempts at 3 months. Started Dec 2018; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT03742154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03742154.